EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The added value of risk assessment and subsequent targeted treatment for epileptic seizures after stroke: An early-HTA analysis

Elles P Elschot, Manuela A Joore, Rob P W Rouhl, Rob J Lamberts, Walter H Backes, Jacobus F A Jansen

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2023.109594 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Elles P Elschot und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P. Debyelaan 25, Maastricht, the Netherlands; MHeNs School for M…. Hauptthemen laut MEDLINE: Stroke, Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The development of post-stroke epilepsy (PSE) is related to a worse clinical outcome in stroke patients. Adding a biomarker to the clinical diagnostic process for the prediction of PSE may help to establish targeted and personalized treatment for high-risk patients, which could lead to improved patient outcomes. We assessed the added value of a risk assessment and subsequent targeted treatment by conducting an early Health Technology Assessment. METHODS: Interviews were conducted with four relevant stakeholders in the field of PSE to obtain a realistic view of the current healthcare and their opinions on the potential value of a PSE risk assessment and subsequent targeted treatment. The consequences on quality of life and costs of current care of a hypothetical care pathway with perfect risk assessment were modeled based on information from a literature review and the input from the stakeholders. Subsequently, the maximum added value (the headroom) was calculated. Sensitivity analyses were performed to test the robustness of this result to variation in assumed input parameters, i.e. the accuracy of the risk assessment, the efficacy of anti-seizure medication (ASM), and the probability of patients expected to develop PSE. RESULTS: All stakeholders considered the addition of a predictive biomarker for the risk assessment of PSE to be of value. The headroom amounted to €12,983. The sensitivity analyses demonstrated that the headroom remained beneficial when varying the accuracy of the risk assessment, the ASM efficacy, and the number of patients expected to develop PSE. DISCUSSION: We showed that a risk assessment for PSE development is potentially valuable. This work demonstrates that it is worthwhile to undertake clinical studies to evaluate biomarkers for the prediction of patients at high risk for PSE and to assess the value of targeted prophylactic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeEpilepsyHumansQuality of LifeTechnology Assessment, BiomedicalBiomarkersSeizuresRisk Assessment

Stichwörter der Autor:innen

Early-HTAHeadroomModified Rankin ScalePost-stroke epilepsyRisk assessmentTargeted treatment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P. Debyelaan 25, Maastricht, the Netherlands; MHeNs School for Mental Health and Neuroscience, Maastricht University, Minderbroedersbe…
  • CAPHRI Care and Public Health Research Institute, Maastricht University, Minderbroedersberg 4-6, Maastricht, the Netherlands; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University…
  • MHeNs School for Mental Health and Neuroscience, Maastricht University, Minderbroedersberg 4-6, Maastricht, the Netherlands; Department of Neurology, Maastricht University Medical Center+, P. Debyelaan 25, Maastricht, t…

Förderung

  • ZonMw

Zitieren

APA

Elschot, E. P., Joore, M. A., Rouhl, R. P. W., Lamberts, R. J., Backes, W. H., & Jansen, J. F. A. (2024). The added value of risk assessment and subsequent targeted treatment for epileptic seizures after stroke: An early-HTA analysis. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109594

Vancouver

Elschot EP, Joore MA, Rouhl RPW, Lamberts RJ, Backes WH, Jansen JFA. The added value of risk assessment and subsequent targeted treatment for epileptic seizures after stroke: An early-HTA analysis. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2023.109594

BibTeX
@article{Elschot2024,
  author = {Elschot, Elles P and Joore, Manuela A and Rouhl, Rob P W and Lamberts, Rob J and Backes, Walter H and Jansen, Jacobus F A},
  title = {The added value of risk assessment and subsequent targeted treatment for epileptic seizures after stroke: An early-HTA analysis},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2023.109594}
}
Kostenlos starten →